The firm will make its artificial intelligence-based Lunit SCOPE IO platform available to SITC member researchers.

Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...

Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...

Native Americans face the longest travel times, even after accounting for distances in rural areas, according to results of a ...

Immunotherapy has shown a 27% reduction in mortality for patients with limited-stage small cell lung cancer, based on Phase ...

Researchers at the Johns Hopkins Kimmel Cancer Center and Bloomberg~Kimmel Institute for Cancer Immunotherapy have developed ...

Researchers reveal that gut microbiota influence the effectiveness of immune checkpoint inhibitors (ICIs) in cancer treatment ...